EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Inherited Retinal Degenerations and Non-Neovascular Age-Related Macular Degeneration: Progress and Unmet Needs

Jacque L Duncan, Angela Bowman, Amy Laster, Claire Gelfman, David G Birch, Shannon E Boye, Stephen P Daiger, Lucian Del Priore, Donald J Zack, James T Handa, Foundation Fighting Blindness Scientific Advisory Board

Translational Vision Science & Technology · 17.12.2024 · 13 (12) · 28

DOI: 10.1167/tvst.13.12.28 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Vision Science & Technology, erschienen am 17.12.2024. Verfasst von Jacque L Duncan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Wayne and Gladys Valley Center for Vision, Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Macular Degeneration, Retinal Degeneration. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inherited retinal degeneration (IRD) disease and age-related macular degeneration (AMD) are leading causes of irreversible vision loss and blindness. Although significant progress has advanced the field in the past 5 years, significant challenges remain. The current article reviews the accomplishments and research advances that have fueled the development of treatments for patients with IRD and AMD, including the first approved gene-augmentation treatment for RPE65-related retinal degeneration and complement inhibition therapies to slow progression of geographic atrophy (GA) in AMD. The article outlines opportunities to address gaps and unmet needs that should lead to additional progress toward the development of treatments for patients with IRDs and non-neovascular AMD in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular DegenerationRetinal DegenerationHumansGenetic TherapyGeographic Atrophycis-trans-IsomerasesRetinoid Isomerohydrolase

Substanzen

cis-trans-IsomerasesRetinoid Isomerohydrolase

Autor:innen und Institutionen

  • Wayne and Gladys Valley Center for Vision, Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA.
  • Foundation Fighting Blindness, Columbia, MD, USA.
  • Rose-Silverthorne Retinal Degenerations Laboratory, Retina Foundation of the Southwest, Dallas, TX, USA.
  • Division of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida, Gainesville, FL, USA.
  • Human Genetics Center, Epidemiology Dept., School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, CT, USA.

Zitieren

APA

Duncan, J. L., Bowman, A., Laster, A., Gelfman, C., Birch, D. G., Boye, S. E., Daiger, S. P., Del Priore, L., Zack, D. J., Handa, J. T., & Foundation Fighting Blindness Scientific Advisory Board (2024). Inherited Retinal Degenerations and Non-Neovascular Age-Related Macular Degeneration: Progress and Unmet Needs. Translational Vision Science & Technology, 13(12), 28. https://doi.org/10.1167/tvst.13.12.28

Vancouver

Duncan JL, Bowman A, Laster A, Gelfman C, Birch DG, Boye SE, et al. Inherited Retinal Degenerations and Non-Neovascular Age-Related Macular Degeneration: Progress and Unmet Needs. Translational Vision Science & Technology. 2024;13(12):28. doi:10.1167/tvst.13.12.28

BibTeX
@article{Duncan2024,
  author = {Duncan, Jacque L and Bowman, Angela and Laster, Amy and Gelfman, Claire and Birch, David G and Boye, Shannon E and Daiger, Stephen P and Del Priore, Lucian and Zack, Donald J and Handa, James T and Foundation Fighting Blindness Scientific Advisory Board, Foundation Fighting Blindness Scientific Advisory Board},
  title = {Inherited Retinal Degenerations and Non-Neovascular Age-Related Macular Degeneration: Progress and Unmet Needs},
  journal = {Translational Vision Science & Technology},
  year = {2024},
  volume = {13},
  number = {12},
  pages = {28},
  doi = {10.1167/tvst.13.12.28}
}
Kostenlos starten →